Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no ...

Purespring Therapeutics has raised $105m in a Series B funding round which will help progress its lead candidate PS-002 to ...

KaliVir Immunotherapeutics has dosed the first subject in a Phase I/Ib trial of VET3-TGI to treat incurable advanced solid ...

Scholar Rock’s stock price increased by 362% after the company announced data from the Phase III SAPPHIRE trial of ...

Johnson & Johnson has discontinued its SunRISe-2 study for TAR-200 in bladder cancer patients not undergoing radical ...

The US FDA has imposed a clinical hold on Kezar Life Sciences’ IND application for zetomipzomib, aimed at treating lupus ...

Cassava Sciences paid $40m after the SEC raised a case about alleged misleading data and misleading investors after a Phase IIb study of its Alzheimer’s drug. Image credit: Shutterstock / Tada Images ...

Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...

The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

Immutep has concluded subject enrolment in the Phase II segment of the AIPAC-003 trial of eftilagimod alpha (efti) to treat ...

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...